Researchers studied the efficacy and safety of dapagliflozin in patients with chronic kidney disease stages 4 and 5. The FDA approved Velphoro (sucroferric oxyhydroxide) for hyperphosphatemia in patients with CKD as young as age 9. Novo Nordisk stopped the phase 3 CLARION-CKD trial of ocedurenone due to disappointing results. With four acquisitions from Fresneius Medical Care, DaVita will become the largest dialysis provider in Latin America. Outset Medical and US Renal Care have partnered to advance home dialysis with the Outset Tablo Hemodialysis System. A bill to improve access to care and outcomes for some dialysis patients was introduced in the House of Representatives. A study examined the risk factors, prevalence, and impact of pruritus associated with CKD in hemodialysis patients. A simulation model predicts a dramatic increase in the impact of chronic kidney disease in the next 10 years. There is wide variability in the timing of initiation of dialysis across the country. The ASN HDU Home Dialysis Scholarship Program will continue in 2024. Humana and Strive Health announced a partnership to provide value-based kidney care to more Medicare Advantage plan members. During an average follow-up of 3.9 years, 12.4% of patients (n=220,339) experienced at least one hyperkalemic episode. Patients with chronic kidney disease (CKD) or end-stage kidney disease (ESKD) face increased health burdens and are at ... Patients with chronic kidney disease (CKD) commonly experience gout, an inflammatory disease associated with higher ... Patients with chronic kidney disease (CKD) are at increased risk for dyskalemias, possibly leading to arrhythmias that ... There has been a decline in the rates of advanced chronic kidney disease (including end-stage renal disease) in patients ... Providing patient-centered care for older adults with advanced chronic kidney disease (CKD) requires patient-clinician ...